PubMed HealthSearch

PubMed · 7444932

A new algorithm for clustering lymphocyte typing sera.

Abstract

An algorithm is presented for clustering antisera by computer. It has two novel features: the leading serum to which all other sera in the cluster are compared is chosen as the most centrally located serum in the cluster; the similarity between two sera is defined from the 2 X 2 table of serum reactions as s = 2a/(2a + b + c). This similarity index is a better measure of the similarity between two sera than conventional measures of similarity such as the correlation coefficient. Finally, the identification of cluster and serum subsets provides a more complete analysis of cross-reactivity and multispecificity, and suggests which absorptions might yield monospecific typing sera. A computer program which performs this serum cluster analysis is available upon request.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C E Kahn, M Curie-Cohen, W H Stone. 1980. A new algorithm for clustering lymphocyte typing sera.. https://doi.org/10.1111/j.1399-0039.1980.tb00207.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Rhesus D typing.

Explore the source record for details and available documents.

Blood Grouping and Crossmatching

A rapid flow cytometry assay for HLA antibody detection using a pooled cell panel covering 14 serological crossreacting groups.

Many studies have demonstrated the usefulness of flow cytometry crossmatching (FC-XM) for selection of regraft recipients, and more recently this assay has been shown to correlate with allograft survival in primary cadaveric transplant patients. The need now exists for a practical antibody screening procedure which uses the same methodology. We describe here a simple and sensitive method to screen for HLA antibodies by FC using a pool of 6 cells selected to cover the 14 serological crossreacting groups defined by Rodey. Screenings of 367 sera (255 primary transplant sera, 112 regraft sera) received for monthly antibody testing were performed by both pooled cell FC and complement-dependent cytotoxicity (CDC) assays. Forty of these sera were also FC-screened using a panel of 16 individual cells for comparison with the pooled cell FC screenings. Analysis indicated a strong correlation between the pooled FC-PRA and the individual cell panel FC-PRA (P = .0001) with mean values of 60% and 73%, respectively. Only 2 of the 40 sera screened by both FC methods resulted in PRAs that differed by > 40%. The majority (82%) of the primary patients did not exhibit HLA antibodies by CDC--however, 22% of the CDC negative patients were positive by flow cytometry. Females were more likely to be positive by FC (35%) than males (16%) (P = .0001). Similarly, black patients were more likely to have FC-demonstrable antibodies (28%) than white candidates (14%) (P = .014). The regraft patients who tested positive by either or all methods had a mean PRA for CDC, pooled FC-PRA, and individual cell FC-PRA of 40, 75, and 85, respectively. FC-PRA proved to be a more sensitive technique in both primary and regraft patients.

Blood Grouping and Crossmatching